North America Hormonal Contraceptive Market Size & Outlook
Related Markets
North America hormonal contraceptive market highlights
- The North America hormonal contraceptive market generated a revenue of USD 7,652.6 million in 2024.
- The market is expected to grow at a CAGR of 4.7% from 2025 to 2030.
- In terms of segment, pill was the largest revenue generating method in 2024.
- Implant is the most lucrative method segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 7,652.6 million |
| Market revenue in 2030 | USD 10,066.3 million |
| Growth rate | 4.7% (CAGR from 2025 to 2030) |
| Largest segment | Pill |
| Fastest growing segment | Implant |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pill, IUD, Injectable, Vaginal Ring, Implant, Patch |
| Key market players worldwide | AbbVie Inc, Afaxys, Teva Pharmaceutical Industries Ltd, Bayer AG, Organon Group of Companies, Pfizer Inc, Agile Therapeutics Inc, Janssen Pharmaceuticals NV, Lupin, Pregna International |
Other key industry trends
- In terms of revenue, North America region accounted for 45.7% of the global hormonal contraceptive market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 10,066.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hormonal Contraceptive Market Scope
Hormonal Contraceptive Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America hormonal contraceptive market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormonal contraceptive market will help companies and investors design strategic landscapes.
Pill was the largest segment with a revenue share of 51.85% in 2024. Horizon Databook has segmented the North America hormonal contraceptive market based on pill, iud, injectable, vaginal ring, implant, patch covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America hormonal contraceptive market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America hormonal contraceptive market databook
-
Our clientele includes a mix of hormonal contraceptive market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America hormonal contraceptive market , including forecasts for subscribers. This continent databook contains high-level insights into North America hormonal contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America hormonal contraceptive market size, by country, 2018-2030 (US$M)
North America Hormonal Contraceptive Market Outlook Share, 2024 & 2030 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
